1. Home
  2. EXPO vs BLCO Comparison

EXPO vs BLCO Comparison

Compare EXPO & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXPO
  • BLCO
  • Stock Information
  • Founded
  • EXPO 1967
  • BLCO 1853
  • Country
  • EXPO United States
  • BLCO Canada
  • Employees
  • EXPO N/A
  • BLCO N/A
  • Industry
  • EXPO Professional Services
  • BLCO Ophthalmic Goods
  • Sector
  • EXPO Consumer Discretionary
  • BLCO Health Care
  • Exchange
  • EXPO Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • EXPO 4.1B
  • BLCO 4.0B
  • IPO Year
  • EXPO 1990
  • BLCO 2022
  • Fundamental
  • Price
  • EXPO $78.28
  • BLCO $12.06
  • Analyst Decision
  • EXPO Strong Buy
  • BLCO Hold
  • Analyst Count
  • EXPO 1
  • BLCO 12
  • Target Price
  • EXPO $120.00
  • BLCO $18.64
  • AVG Volume (30 Days)
  • EXPO 378.7K
  • BLCO 939.1K
  • Earning Date
  • EXPO 05-01-2025
  • BLCO 04-30-2025
  • Dividend Yield
  • EXPO 1.51%
  • BLCO N/A
  • EPS Growth
  • EXPO 8.76
  • BLCO N/A
  • EPS
  • EXPO 2.11
  • BLCO N/A
  • Revenue
  • EXPO $518,490,000.00
  • BLCO $4,791,000,000.00
  • Revenue This Year
  • EXPO $4.77
  • BLCO $6.30
  • Revenue Next Year
  • EXPO $7.69
  • BLCO $5.56
  • P/E Ratio
  • EXPO $37.10
  • BLCO N/A
  • Revenue Growth
  • EXPO 4.28
  • BLCO 15.56
  • 52 Week Low
  • EXPO $73.83
  • BLCO $10.46
  • 52 Week High
  • EXPO $115.75
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • EXPO 41.70
  • BLCO 38.44
  • Support Level
  • EXPO $73.83
  • BLCO $11.62
  • Resistance Level
  • EXPO $81.04
  • BLCO $12.38
  • Average True Range (ATR)
  • EXPO 2.94
  • BLCO 0.89
  • MACD
  • EXPO 0.25
  • BLCO -0.03
  • Stochastic Oscillator
  • EXPO 47.54
  • BLCO 37.74

About EXPO Exponent Inc.

Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: